Usefulness of C-Reactive Protein for Evaluating Clinical Outcomes in Cirrhotic Patients with Bacteremia
Open Access
- 1 January 2011
- journal article
- research article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 26 (2) , 195-200
Abstract
The purpose of this study was to evaluate the value of initial C-reactive protein (CRP) as a predictor of clinical outcome and to investigate whether follow-up CRP measurement is useful for the prediction of the clinical outcome of bloodstream infections in patients with liver cirrhosis (LC), whose CRP production in response to infection may be attenuated. A retrospective, observational study including 202 LC patients with Escherichia coli or Klebsiella pneumoniae bacteremia was conducted to assess the usefulness of serial CRP measurements in predicting clinical outcome in LC patients. The CRP ratio was defined as the ratio of the follow-up CRP level to the initial CRP level. The overall 30-day mortality rate of the study population was 23.8% (48/202). In the multivariate analysis, advanced age (≥ 70 years), healthcare-associated or nosocomial infections, model for end-stage liver disease (MELD) score of ≥ 30, and initial body temperature of < 37℃ were significant factors associated with mortality (all p < 0.05). No association between initial CRP level and mortality was found. In a further analysis including 87 evaluable cases who had repeated CRP measurements at day 4 and/or 5, a CRP ratio of ≥ 0.7 was found to be a significant factor associated with mortality (odds ratio, 19.12; 95% confidence interval, 1.32 to 276.86; p = 0.043) after adjusting for other confounding variables. Initial CRP level did not predict mortality of sepsis in LC patients. However, serial CRP measurements during the first week of antimicrobial therapy may be useful as a prognostic factor for mortality in LC patients.Keywords
This publication has 16 references indexed in Scilit:
- C-Reactive Protein Is an Independent Predictor of Severity in Community-acquired PneumoniaThe American Journal of Medicine, 2008
- Prognostic Value of Serial C-Reactive Protein Measurements in Left-Sided Native Valve EndocarditisArchives of internal medicine (1960), 2008
- Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical courseCritical Care, 2007
- C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunctionIntensive Care Medicine, 2006
- Pilot Study Evaluating C-Reactive Protein Levels in the Assessment of Response to Treatment of Severe Bloodstream InfectionClinical Infectious Diseases, 2005
- C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot studyEuropean Respiratory Journal, 2005
- Production of C-reactive protein in Escherichia coli-infected patients with liver dysfunction due to liver cirrhosisDiagnostic Microbiology and Infectious Disease, 2005
- C-reactive protein as a marker of infection in critically ill patientsClinical Microbiology and Infection, 2005
- Interleukin-6: an early marker of bacterial infection in decompensated cirrhosisJournal of Hepatology, 1994
- THE LIVER AS THE SITE OF C-REACTIVE PROTEIN FORMATIONJournal of Experimental Medicine, 1966